Alecensa TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: alectinib
Pack: Alecensa 150 mg capsule, 4 x 56, blister packs
Brand name
(ARTG)
: ALECENSA alectinib hydrochloride 150 mg hard capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Adjuvant treatment of resected non-small cell lung cancer,Alecensa is indicated as adjuvant treatment in adult patients following tumour resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours equal to or greater than 4 cm or node positive).,Treatment of metastatic NSCLC,Alecensa is indicated for the treatment of patients with ALK-positive, locally advanced or metastatic NSCLC.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- hard white capsules with ALE printed in black ink on the cap and 150 mg printed in black ink on the body
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 5 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 224 hard capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient alectinib
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
